The cytokine network in chronic obstructive pulmonary disease.

Multiple cytokines play a role in the orchestration of inflammation in inflammatory airway diseases, such as chronic obstructive pulmonary disease, through the recruitment, activation and survival of inflammatory cells. Lymphokines secreted from T cells regulate the pattern of inflammation, whereas proinflammatory cytokines amplify and perpetuate the inflammatory response. Multiple chemokines recruit inflammatory cells from the circulation into the lungs and many growth factors maintain this inflammation and lead to characteristic structural changes in the airways. There are several therapeutic approaches that target cytokine-mediated inflammation in chronic obstructive pulmonary disease, but blocking specific cytokines may not provide clinical benefit, whereas broad-spectrum anti-inflammatory approaches are more likely to be clinically effective.

[1]  Alvar Agusti,et al.  Immunologic aspects of chronic obstructive pulmonary disease. , 2009, The New England journal of medicine.

[2]  Parameswaran Nair,et al.  Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. , 2009, The New England journal of medicine.

[3]  I. Adcock,et al.  T helper type 17‐related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients , 2009, Clinical and experimental immunology.

[4]  C. Roussos,et al.  Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease. , 2009, Respiratory medicine.

[5]  P. J. Barnes,et al.  Systemic manifestations and comorbidities of COPD , 2009, European Respiratory Journal.

[6]  V. Kim,et al.  Lymphoid follicle cells in chronic obstructive pulmonary disease overexpress the chemokine receptor CXCR3. , 2009, American journal of respiratory and critical care medicine.

[7]  R. Stockley,et al.  Imbalances Between Interleukin-1 and Tumor Necrosis Factor Agonists and Antagonists in Stable COPD , 2009, Journal of Clinical Immunology.

[8]  Ana Sousa,et al.  Mepolizumab and exacerbations of refractory eosinophilic asthma. , 2009, The New England journal of medicine.

[9]  Ashok Kumar,et al.  The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. , 2009, Inflammation & allergy drug targets.

[10]  C. Paige,et al.  IL-21: An Executor of B Cell Fate1 , 2009, The Journal of Immunology.

[11]  P. Barnes,et al.  Role of HDAC2 in the pathophysiology of COPD. , 2009, Annual review of physiology.

[12]  J. Phillips,et al.  CXCR2 antagonists for the treatment of pulmonary disease. , 2009, Pharmacology & therapeutics.

[13]  P. Barnes Emerging pharmacotherapies for COPD. , 2008, Chest.

[14]  P. Barnes,et al.  The cytokine network in asthma and chronic obstructive pulmonary disease. , 2008, The Journal of clinical investigation.

[15]  C. Dinarello,et al.  IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. , 2008, American journal of respiratory and critical care medicine.

[16]  D. Spina,et al.  PDE4 inhibitors: current status , 2008, British journal of pharmacology.

[17]  Xiao-Dong Yang,et al.  Association of interleukin (IL)-12 and IL-27 gene polymorphisms with chronic obstructive pulmonary disease in a Chinese population. , 2008, DNA and cell biology.

[18]  B. O'connor,et al.  Expression and Cellular Provenance of Thymic Stromal Lymphopoietin and Chemokines in Patients with Severe Asthma and Chronic Obstructive Pulmonary Disease1 , 2008, The Journal of Immunology.

[19]  L. Donnelly,et al.  Th17 cells in airway diseases. , 2008, Current molecular medicine.

[20]  Rob Leurs,et al.  Towards Small‐Molecule CXCR3 Ligands with Clinical Potential , 2008, ChemMedChem.

[21]  M. Tsoumakidou,et al.  Dendritic cells in chronic obstructive pulmonary disease: new players in an old game. , 2008, American journal of respiratory and critical care medicine.

[22]  M. Feldmann,et al.  Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics , 2008, Immunological reviews.

[23]  E. Barillot,et al.  A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses , 2008, Nature Immunology.

[24]  S. Holgate,et al.  Dynamics of pro-inflammatory and anti-inflammatory cytokine release during zcute inflammation in chronic obstructive pulmonary disease: an ex vivo study , 2008, Respiratory research.

[25]  D. Littman,et al.  The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt , 2008, Nature Immunology.

[26]  J. Steinke,et al.  The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. , 2008, The Journal of allergy and clinical immunology.

[27]  J. Clancy,et al.  A Novel Proteolytic Cascade Generates an Extracellular Matrix-Derived Chemoattractant in Chronic Neutrophilic Inflammation12 , 2008, The Journal of Immunology.

[28]  S. Medicherla,et al.  p38α-Selective Mitogen-Activated Protein Kinase Inhibitor SD-282 Reduces Inflammation in a Subchronic Model of Tobacco Smoke-Induced Airway Inflammation , 2008, Journal of Pharmacology and Experimental Therapeutics.

[29]  E. Mercken,et al.  Effect of Infliximab on Local and Systemic Inflammation in Chronic Obstructive Pulmonary Disease: A Pilot Study , 2008, Respiration.

[30]  P. Barnes Immunology of asthma and chronic obstructive pulmonary disease , 2008, Nature Reviews Immunology.

[31]  P. Paré,et al.  Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. , 2008, American journal of respiratory and critical care medicine.

[32]  M. Hudson,et al.  TNF-α antagonists and the prevention of hospitalisation for chronic obstructive pulmonary disease ☆ , 2008 .

[33]  H. Aizawa,et al.  Interleukin-18 production and pulmonary function in COPD , 2008, European Respiratory Journal.

[34]  L. Fabbri,et al.  Increased activation of p38 MAPK in COPD , 2008, European Respiratory Journal.

[35]  P. Barnes,et al.  CXCR3 and CCR5 chemokines in induced sputum from patients with COPD. , 2008, Chest.

[36]  J. Curtis,et al.  The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. , 2007, Proceedings of the American Thoracic Society.

[37]  C. Akdis,et al.  TH17 cells in the big picture of immunology. , 2007, The Journal of allergy and clinical immunology.

[38]  Lianyu Shan,et al.  Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[39]  A. D. Panopoulos,et al.  Essential autocrine regulation by IL-21 in the generation of inflammatory T cells , 2007, Nature.

[40]  Y. Wan,et al.  Regulatory T Cells, Transforming Growth Factor–β, and Immune Suppression , 2007 .

[41]  K. Rabe,et al.  Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD , 2007, Thorax.

[42]  P. Barnes Unexpected failure of anti-tumor necrosis factor therapy in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[43]  S. Rennard,et al.  The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[44]  B. Pedersen,et al.  Elevated Levels of IL-18 in Plasma and Skeletal Muscle in Chronic Obstructive Pulmonary Disease , 2007, Lung.

[45]  Tomoki Ito,et al.  TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. , 2007, Annual review of immunology.

[46]  June Qin,et al.  Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor. , 2007, Blood.

[47]  A. Churg,et al.  Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall. , 2006, American journal of respiratory and critical care medicine.

[48]  I. Douglas,et al.  Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease? , 2006, Proceedings of the American Thoracic Society.

[49]  A. Nicholson,et al.  Inhibitory effect of p38 mitogen‐activated protein kinase inhibitors on cytokine release from human macrophages , 2006, British journal of pharmacology.

[50]  P. Barnes,et al.  Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease. , 2006, Trends in pharmacological sciences.

[51]  I. Adcock,et al.  Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease. , 2006, The Journal of allergy and clinical immunology.

[52]  A. Kraneveld,et al.  A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation , 2006, Nature Medicine.

[53]  P. Hiemstra,et al.  Expression of epidermal growth factors and their receptors in the bronchial epithelium of subjects with chronic obstructive pulmonary disease. , 2006, American journal of clinical pathology.

[54]  J. Nadel,et al.  Neutrophil Elastase Induces MUC5AC Mucin Production in Human Airway Epithelial Cells via a Cascade Involving Protein Kinase C, Reactive Oxygen Species, and TNF-α-Converting Enzyme1 , 2005, The Journal of Immunology.

[55]  P. Hudson,et al.  Engineered antibody fragments and the rise of single domains , 2005, Nature Biotechnology.

[56]  V. Barbour,et al.  Ten Questions about Diabetes Mellitus , 2004 .

[57]  P. Barnes Mediators of Chronic Obstructive Pulmonary Disease , 2004, Pharmacological Reviews.

[58]  I. Adcock,et al.  Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease , 2004, Histopathology.

[59]  Naftali Kaminski,et al.  Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Y. Castier,et al.  Decreased expression of interleukin 13 in human lung emphysema , 2004, Thorax.

[61]  A. Churg,et al.  Tumor Necrosis Factor-α Drives 70% of Cigarette Smoke–induced Emphysema in the Mouse , 2004 .

[62]  I. Adcock,et al.  STAT4 activation in smokers and patients with chronic obstructive pulmonary disease , 2004, European Respiratory Journal.

[63]  P. Paré,et al.  The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[64]  H. Sarau,et al.  The FASEB Journal express article 10.1096/fj.03-0170fje. Published online Novermber 3, 2003. Regulation of TNF-α and IFN-γ induced CXCL10 , 2022 .

[65]  P. Barnes,et al.  High levels of interleukin-6 in the exhaled breath condensate of patients with COPD. , 2003, Respiratory medicine.

[66]  R. Atmar,et al.  Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[67]  Y. Ho,et al.  Stimulation of Airway Mucin Gene Expression by Interleukin (IL)-17 through IL-6 Paracrine/Autocrine Loop* , 2003, The Journal of Biological Chemistry.

[68]  K. Hirata,et al.  Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. , 2003, The American journal of medicine.

[69]  P. Shah,et al.  Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[70]  P. Barnes,et al.  Increased levels of the chemokines GROα and MCP-1 in sputum samples from patients with COPD , 2002, Thorax.

[71]  P. Barnes,et al.  Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[72]  L. Fabbri,et al.  Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[73]  L. Fabbri,et al.  Exacerbations of Bronchitis: bronchial eosinophilia and gene expression for interleukin-4, interleukin-5, and eosinophil chemoattractants. , 2001, American journal of respiratory and critical care medicine.

[74]  I. Adcock,et al.  Decreased T lymphocyte infiltration in bronchial biopsies of subjects with severe chronic obstructive pulmonary disease , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[75]  M. Cosio,et al.  Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. , 2001, The European respiratory journal.

[76]  F. Yamasawa,et al.  Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). , 2001, American journal of respiratory and critical care medicine.

[77]  J. Nadel,et al.  Relationship of epidermal growth factor receptors to goblet cell production in human bronchi. , 2001, American journal of respiratory and critical care medicine.

[78]  K. Wright,et al.  Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[79]  P. Hirth,et al.  Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. , 2000, The Journal of clinical investigation.

[80]  P. Hiemstra,et al.  Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD , 2000, The Journal of pathology.

[81]  T. Seemungal,et al.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations , 2000, Thorax.

[82]  P. Hiemstra,et al.  Transforming Growth Factor β1 and Recruitment of Macrophages and Mast Cells in Airways in Chronic Obstructive Pulmonary Disease , 1998 .

[83]  B. Balbi,et al.  Increased bronchoalveolar granulocytes and granulocyte/macrophage colony-stimulating factor during exacerbations of chronic bronchitis. , 1997, The European respiratory journal.

[84]  P. Barnes,et al.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.